Life Science Connect acquires BrevisRefero
Toronto-based BrevisRefero, founded in 2017 by Terry Cochrane, provides biopharma consulting and the RFP>Navigator platform for CDMO sourcing.
Latticework portfolio company Life Science Connect has acquired BrevisRefero Corporation, a Toronto-based biopharma consulting firm and developer of RFP>Navigator. The platform is designed to make CDMO sourcing and RFP management faster and more structured.
RFP>Navigator lets biopharma innovators manage RFPs and NDAs, engage providers, track proposals and compare responses on pricing, capabilities, quality and regulatory experience. The company says it can cut the time to build a qualified shortlist from six to eight months to six to eight weeks.
BrevisRefero's consulting business will continue alongside the platform. Life Science Connect plans to promote RFP>Navigator across its outsourcing audiences and CDMO Live events. CEO Jon Howland said the deal helps innovators save time and money in lengthy sourcing processes.
Deal facts
- Target
- BrevisRefero
- Business
- Toronto-based biopharma consulting company and developer of RFP>Navigator, a digital platform for CDMO sourcing and RFP management
- Acquirer
- Life Science Connect
- Seller
- Terry Cochrane (founder)
- Deal type
- Add-on
- Headquarters
- Toronto, Ontario
- Status
- Completed
- Announced
- Monday, October 19, 2026
Sources
- Latticework Capital ManagementOct 29, 2026
- finance.yahoo.comOct 19, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.